Nuclear Medicine and PET Scan Outpatient Order Form All Orders Require a Signature from the Provider to Process for Driving Dire

Total Page:16

File Type:pdf, Size:1020Kb

Nuclear Medicine and PET Scan Outpatient Order Form All Orders Require a Signature from the Provider to Process for Driving Dire BirthName Date (Last) Maiden or Previous Name (First) Sex (M.I) M F Ordering Physician/Provider: PrimaryBirth Date Diagnosis(es) & ICD-9Maiden orCode(s)DIAGNOSTI Previous orName SymptomsCS AND ULTRASOUNDSex Ordering Physician/Provider: Nuclear Medicine and PET ScanM F DIAGNOSTIOUTOutpatientPATIENTC Order SORDER AND Form U FORMLTRASOUND Primary Diagnosis(es) & ICD-9 Code(s)OUTPA orTIENT Symptoms ORDER FORM Name (Last) (First)(First) (M.I) All orders require a signature from the provider to process Name (Last) (First) (M.I) BiBirthrth Date Maiden or PrPreviousevious Name SexSex ProviderAll orders Signature: require_______________________________________________________________ a signature from the provider___________________________________________________ to process Birth Date Maiden or Previous Name Date Sex TimeM F Visit/Encounter # Unit Med. Record # Print Provider Name: ________________________________________________________________________________________________________________________________________________________________________________M F PProviderPrimaryrimary Diagnosis(es)Signature:_______________________________________________________________ & ICD-9ICD-10 Code(s) Code(s) or or Symptoms Symptoms___________________________________________________ SPrimarychedul eDiagnosis(es) Appt Patie &nt ICD-9will ca llCode(s) 269-341-8700 or Symptoms Fax OrDatdere to 269-343-427Time 7 Visit/Encounter # Unit Med. Record # BPrintLH SProvidercheduling Name: 269-657-1441_______________________________________________________________ BLH Fax 269-657-1339_______________________________________________________________ Phys__________________________________________________ician will call DoesSAllch ordersedul patiente A pprequire meett criteriaP ata iesignaturen tfor will Hydration call 269-341-8700 from Protocol? the prprovider o videryesFax to O processrnoder Labto 269-343-427 result date 7_______________ Allergies yes no GFR:____________BAllLH orders Scheduling require 269-657-1441 a Creatinine:____________ signature BLH from Fax 269-657-1339the provider (within 30 to daysprocessPh ysof ischeduledcian will ca examll or new labs must be drawn) Allergy to X-ray Dye\Contrast yes no DoesPrProviderovider patient Signature: meetADDITIONAL criteria_______________________________________________________________ for HydrationCLINICAL Protocol? DATA/SIGNS yes___________________________________________________ & SYMPTOMSno Lab result date _______________ AllergiesADDITIONAL yes no INSTRUCTIONS Visit/EncounterVisit/Encounter # Unit MedMed.. RecordRecord ## GFR:____________Provider Signature: _______________________________________________________________ Creatinine:____________ (within___________________________________________________ 30 daysDateDate of scheduled TimeTime exam or new labs must be drawn) Allergy to X-ray Dye\Contrast yes no THIS WEBSITE CAN BE USED IF YOU DO NOT HAVE YOUR OWN CLINICAL DECISION SUPPORT SYSTEM: PPrintrint ProviderProvider Name:ADDITIONAL_______________________________________________________________ CLINICAL DA_______________________________________________________________TA/SIGNS & SYMPTOMSDate__________________________________________________Time Vhttps://qcdsm.nationaldecisionsupport.com/isit/Encounter # ADDITIONAL Unit INSTRUCTIONS Med. Record # Print Provider Name: ________________________________________________________________________________________________________________________________________________________________________________ CLINICAL DECISION NUMBER or SESSION ID:________________________________________ ToSch Scheduleedule App callt 269-341-8700.Patient will call Fax269-341-8700 Order to 269-343-4277 Fax Order to 269-343-4277 DECISION SUPPORT APPROPRIATENESS SCORE:______________________________________ DECISION SUPPORT VENDOR:________________________________________________________ BLHSBBBCcLhHe SdulSchedulingchee Adulingppt 269-657-1441269-245-8666 269-657-1441Patient will ca B BBC llLBLH H269-341-8700 FFax axFax 269-657-1339269-245-4902 269-657-1339 F ax OrdReadPher ysto icand269-343-427ian fax:will call 7 DECISION SUPPORT ADHERENCE or CONSULTATION RESULTS:__________________________ BDoesPleLHa S sepcatienth reaedulingd NUCLEARmeet the 269-657-1441 followingcriteria MEDICINEfor Hydrationstatem BLH Feaxnt Protocol? 269-657-1339to the pati eyesnt ' s insurnoPh Labysanic ieresultan co willm date capallny _______________ and record the a uth o Allergiesrization numyesbe r onon the blank after the statement. "I am SIGNS AND SYMPTOMS INTRAVENOUS____________ CONTRAST___________ GFR:____________calling for authorizationEndocrine Creatinine:____________ ofSystem (the ordered pro (withincedur e30) for days both of scheduled the facility exam and or the new pr labsovid muster int beer pdrawn)retation." Allergy Auth otoriz X-rayation D Numbye\Contraster yes no . Does patient meet criteria for Hydration Protocol? yes no Lab result date _______________ Allergies yes no (Must check one box) TGFR:____________Plehyroidase reaUptaGENERALd thekADDITIONALe and following Creatinine:____________XRScaAYn statemCLINICALent D78014toA TtheA/SIGNS pati(withineGENERALnt &30's SYMPTOMS insurdays aof XRn scheduledceA Ycompa examny a ndor new*rPHYSICIAN’S/PROVIDER’SGEecoN labsErdRAL th must eXR aA uthYbe * Sodrawn)PrizECIALatio nSTADDITIONAL AllergynumUDIESbe ORDERS tor X-rayon INSTRUCTIONSth eD yblae\Contrastnk aftUeLr TRASOUNDtheyes st a t e ment.no "I am * With IV contrast TchalyroidlCHEST/RESPIRing f oUptar authorizationke ATORY/RI of (the BordereS 78012d pUPPERrocedur eEXTREMITIES) for both the fa (Cont.)cility and the GASTROINTESTINALprovider interpretation." F ALuthUOROorization Number___ABDOMEN____________________. ADDITIONAL CLINICAL DATA/SIGNS & SYMPTOMS SPECIFIC EXAMS ORDEREDADDITIONAL INSTRUCTIONS Without IV contrast PaCHESTrathyroidGENERAL PA Gland & LAT (ROUTINEwith XR ASpecY )t 7102078071FOREARMGENERAL XRRTAY LT 73090 *GE*ESOPHAGUSNERAL XRAY *SPECIAL STUDIES 74220 ABD - COMPLETEULTRASOUND 76700 PET SCAN (Must check one box) * ThyroidCHESTCHEST/RESPIR Scan PA ON OnlyLY ATORY/RIB71010S 78018WRISTUPPER EXTREMITIES (Cont.) GASTROINTESTINAL*VIDEO FLUOROSCOPIC FLUORO74230 ABD - QUADRANTABDOMEN - SPECIFY 76705 PET-CT whole torso (eyes to thighs) 78815 CHESTNECK FOR PGastrointestinalA &SO LAFTT (ROUTINETISSUE System) 7036071020 FOREARM3 VIEW RT LT 7309073110 *ESOPHAGUSSWALLOW STUDY 74220 GALLABD - BLADDERCOMPLETE 7670076705 PET-CT limited (neck and thorax) 78814 LiPlveasCHESTRIerB BileSe (INCre adPTAranspoL ONUDEtheL Yfo PrAltl o ScanCHEST)wing statement71010 78226to theHANDWRIST patient's insurance company and reco*VIDEO*UPPERrd th eF GI LaUOROSCOPICuthorization numbe7424074230r on the LIVERABDblan k- QaUfteADRANTr the st a- tSPECIFement.Y "I a76705m Liver Bile Transport Scan w PET-CT whole body (skull vertex to toes) 78816 PcaleasNECKllingUNILe freo FORrAad TERALauthoriz theSOF foT laTIlotiSwingoSUnRT ofE st(theaLtementT ordere7036071101 78227tod theprocedur 3pati VIEWente')s forinsur boathn ctheeRT c ompf aciLlTityany7313073110 an adnd th ereco p*UPPERSroWrviderdAL thLeOW G.I. intauth e STUWITHrpretation."orizDY ESOPHAGUSation num Authbeo74240rizr oanti thone NumbGALLPblaANCREASnk BLADDER earft__er_ __the_ _st_a___tement._____ _"I_ a_76705m__ __. with Pharmacologic Intervention PET-CT brian 78608 caRIllingBBILS f(INCAoGENERALTERALr aLuthorizUDE PAa XRtiCHEST)onA Yof (the ordere71111 d procedurFINGERSHAND GENERALe) for bo thXR theARTY f aciLlityT 73140 and th*eGE p*UPPER*SMALLrNoEviderRAL XRBGI intOWELAYe *rpretation."SPECIAL STUDI AuthESo7424074250rization NumbLIVERRENALe TRANSPLANr__UL_TRASOUND________T ________7670576776____. G.I. Blood Loss Scan 78278 * CHEST/RESPIRUNILGENERALATERALABDOMEN XRATORY/RIARTY LTB71101S INUPPERF3AN VIEWTGENERALCOMPLETE EXTREMITIES XR UPPERARTY (Cont.)EXLT 73130 *GEGASTROINTESTINAL*UPPER*BARIUMNECRALT-INTERPRE XR G.I. ENEMAAY WITH *SPE C ESOPHAGUST I AA L TION S TUDI F74270/74280LUOROES 74240 PAORANCREASTA ULABDOMENTRASOUND 7670576775 Meckel’s Scan 78290 73092 * BILATERAL 71111 (0-18 MOS) G.EABDCHESTCHEST/RESPIR. Reflux FL APTA or PL& LAMilkATE/SUPINT (ROUTINE ScanATORY/RIE ) B740007104671020S 78262FOREARMFINGERSUPPER EXTREMITIESRT (Cont.)LT 7309073140 GASTROINTESTINAL*SMALL*POST*ESOPHAGUSCT OP( B OWELabdomenT-TUBE) F L CTUORO 759847425074220neck RENALKIDNEYSABD CT - pelvisCOMPLETE TRANSPLAN &ABDOMEN BLADDE CTTR thorax 767767677076700 ABDCHEST FL APTA &&ONABDOMEN UPRIGHLALYT (ROUTINET ) 74020710457101071020 FOREARMINWRISTFANTPECOMPLETELVIS AND UPPER RTHIPS EXLT 73090 *VIDEO*BARIUM*ESOPHAGUS*URINARY F LENEMAUOROSCOPIC SYSTEM 74270/742807422074230 AORSPLEENABD T- AQCOMPLETEUADRANT - SPECIFY 767757670576700 Gastric Emptying Scan 78264 73092 ABDNECKCHEST FLACUTE FOR APTAGenitourinary PL ONSO (INCALTE/SUPINFYTL TIUDESSSUE P ASystem CHEST)74022740007101070360 PEWRIST(3L0-18 VISVIEW APMOS) RT LT 7217073110 *VIDEO*POSTKSUBW AL(NO LOP( OWF LAPPOINTMENTUOROSCOPICT -STUTUBE)DY NEEDED)759847402074230 KIDNEYSABDGALL - BLADDERDOPPLERQU ADRANT& BLADDE - SPECIFR Y 939757677076705 RenoABDNECKRIBgrS FLam(INC FORA T(routine)L & UDESO UPRIGHHEADF TP ATI CHEST)STSUE 740207036078707HIPHAND3 VIEWPELVIS AND RTHIPS LT 7357311002 *I.*UPPERSVW. PALYE*URINARYLOW LGIOGRAM STUDY SYSTEM 7440074240 SPLEENLIVERGALL BLADDERPELVIS 76705 RenoSABDRIKBUNILULLgS r ACUTEam(INC COMPLETEA TERALGlomeLUDE (INC PrLAularUDES CHEST)RT P A CHEST)LT 740227026071101 PEHAND3L VISVIEW AP RT LT 7217073130 *CYSTOGRAPHYK*UPPERUB (NO G.I.GI APPOINTMENT WITH ESOPHAGUS NEEDED)740207443074240 ABDPLIVERPEANCREASLVIS - DOPPLER 768569397576705
Recommended publications
  • A Comparison of Imaging Modalities for the Diagnosis of Osteomyelitis
    A comparison of imaging modalities for the diagnosis of osteomyelitis Brandon J. Smith1, Grant S. Buchanan2, Franklin D. Shuler2 Author Affiliations: 1. Joan C Edwards School of Medicine, Marshall University, Huntington, West Virginia 2. Marshall University The authors have no financial disclosures to declare and no conflicts of interest to report. Corresponding Author: Brandon J. Smith Marshall University Joan C. Edwards School of Medicine Huntington, West Virginia Email: [email protected] Abstract Osteomyelitis is an increasingly common pathology that often poses a diagnostic challenge to clinicians. Accurate and timely diagnosis is critical to preventing complications that can result in the loss of life or limb. In addition to history, physical exam, and laboratory studies, diagnostic imaging plays an essential role in the diagnostic process. This narrative review article discusses various imaging modalities employed to diagnose osteomyelitis: plain films, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, bone scintigraphy, and positron emission tomography (PET). Articles were obtained from PubMed and screened for relevance to the topic of diagnostic imaging for osteomyelitis. The authors conclude that plain films are an appropriate first step, as they may reveal osteolytic changes and can help rule out alternative pathology. MRI is often the most appropriate second study, as it is highly sensitive and can detect bone marrow changes within days of an infection. Other studies such as CT, ultrasound, and bone scintigraphy may be useful in patients who cannot undergo MRI. CT is useful for identifying necrotic bone in chronic infections. Ultrasound may be useful in children or those with sickle-cell disease. Bone scintigraphy is particularly useful for vertebral osteomyelitis.
    [Show full text]
  • Members | Diagnostic Imaging Tests
    Types of Diagnostic Imaging Tests There are several types of diagnostic imaging tests. Each type is used based on what the provider is looking for. Radiography: A quick, painless test that takes a picture of the inside of your body. These tests are also known as X-rays and mammograms. This test uses low doses of radiation. Fluoroscopy: Uses many X-ray images that are shown on a screen. It is like an X-ray “movie.” To make images clear, providers use a contrast agent (dye) that is put into your body. These tests can result in high doses of radiation. This often happens during procedures that take a long time (such as placing stents or other devices inside your body). Tests include: Barium X-rays and enemas Cardiac catheterization Upper GI endoscopy Angiogram Magnetic Resonance Imaging (MRI) and Magnetic Resonance Angiography (MRA): Use magnets and radio waves to create pictures of your body. An MRA is a type of MRI that looks at blood vessels. Neither an MRI nor an MRA uses radiation, so there is no exposure. Ultrasound: Uses sound waves to make pictures of the inside of your body. This test does not use radiation, so there is no exposure. Computed Tomography (CT) Scan: Uses a detector that moves around your body and records many X- ray images. A computer then builds pictures or “slices” of organs and tissues. A CT scan uses more radiation than other imaging tests. A CT scan is often used to answer, “What does it look like?” Nuclear Medicine Imaging: Uses a radioactive tracer to produce pictures of your body.
    [Show full text]
  • INTERPRETATION of the 67Gd PHOTOSCAN
    INTERPRETATION OF THE 67Gd PHOTOSCAN Steven M. Larson, Michael S. Milder, and Gerald S. Johnston National Institutes of Health, Bethesda, Maryland Gallium-67 citrate is used to locate sites of of these investigators was not achieved, several im tumor involvement throughout the body. In or portant observations were made. The distribution of der to make proper use of this new agent, a carrier-free "7Ga was predominantly found within knowledge of the normal ' t.u distribution and the liver, spleen, kidney, and bone in rats. The addi physiological variations is necessary. For this tion of stable gallium caused a progressive increase report, over 400 whole-body rectilinear scans in relative concentration within the skeleton and a using 35 fid/kg "~Ga citrate were reviewed. At relative decrease in soft tissue concentration. As a 48 hr, normal 6~Ga activity is concentrated in result of this early work, ^Ga with a carrier was the axial skeleton, liver, spleen, and around the later evaluated as a bone scanning agent, and it was large joints. Foci of uptake are often seen in while scanning the bones of a patient with Hodgkin's the salivary, lacrimal, and mammary glands. disease that the tumor-specific properties of 67Ga- Activity is also found in the region of the naso citrate were discovered (2). pharynx. Under certain physiological condi The distribution of 07Ga in humans has subse tions, intense localisation may occur within the quently been studied (77-73). When carrier-free breast, bowel, and long bones. These variations 07Ga-citrate is injected intravenously, the majority may mimic malignant tumors.
    [Show full text]
  • GALLIUM SCAN Information Brochure
    GALLIUM SCAN Information Brochure North Shore Radiology & Nuclear Medicine North Shore Private Hospital Westbourne Street, St Leonards 2065 Tel: (02) 8425 3684, Fax: (02) 8425 3688 Nuclear Medicine Physicians Dr Elizabeth Bernard FRACP Dr Paul Roach FRACP INSTRUCTIONS FOR PATIENTS HAVING A GALLIUM SCAN What is it? This is a test which is used to detect a variety of conditions, including infections, abscesses and certain tumours such as lymphoma. How is the test done and how long does it take? The test involves an injection into a vein of a small amount of a radioactive compound called Gallium. A specialised camera is then used to take pictures of your body. On the first day, the test will be explained to you and a technologist will give you the injection gallium (this only takes no more than 15 minutes). You will return two days later for the scan which may take 30-90 minutes depending on what your doctor is looking for. (You are not scanned earlier because it takes several days for any abnormality to appear on the scan.) You may need to return for further scans over the next few days as gallium is normally excreted into the bowel and it may take up to 1 week for the bowel to clear. Is it painful and are there any side effects? No. There are no side effects or reactions from the injection. The injection does NOT contain iodine and is therefore safe to give even if you have had a previous allergic reaction to contrast injections. Although you will be required to keep still during the scan, the procedure itself is completely painless.
    [Show full text]
  • Gallium Study: Performed to Detect Or Localize Areas of Chronic Infection Or Tumors • There Are No Preparations Needed For
    Gallium Study: performed to detect or localize areas of chronic infection or tumors There are no preparations needed for this exam; although it would be beneficial if the patient is well-hydrated and only if it does not interfere with other testing or procedures. If a gallium scan is needed, it should be done before any tests that use barium (such as a barium enema). Taking a medicine (such as Pepto-Bismol) that contains bismuth can also interfere with a gallium scan. In some cases, patients may be required to do a mild bowel prep prior to or upon completion of this study. If the patient is under the age of 50 and has NOT had a hysterectomy, a urine pregnancy test will be required at no charge to the patient. The patient needs to arrive 30 minute prior to the appointment time for the pregnancy test to be administered. If the patient is breast feeding, please consult the department for further instruction. The duration of this exam can range from six to 72 hours. The patient is injected with a radioactive tracer in the vein. The patient returns to the Radiology department six hours after the time of the injection. The patient lies on the imaging table and is scanned from the head to mid-thigh or over a particular area of interest. Imaging takes about 1 hour. The patient returns at 24 hours and again at 48 hours to repeat the scan. The patient may also need to return after 72 hours for another scan. The patient is asked to bring any prior films or reports of x-rays, ultrasound, MRI or CT scans ONLY if the studies were NOT performed at United Regional.
    [Show full text]
  • PET/CT & Nuclear Medicine in Clinical Practice
    The 8 th | Snowmass 2017: PET/CT & Nuclear Medicine in Clinical Practice Friday, February 24, 2017 Westin Snowmass Resort • Snowmass Village, Colorado Educational Symposia TABLE OF CONTENTS FRIDAY, FEBRUARY 24, 2017 Fluoride PET/CT Bone Imaging (Kevin L. Berger, M.D.) ................................................................................................. 221 Bone Scintigraphy (Andrew T. Trout, M.D.) .................................................................................................................. 235 Improving Efficiency in PET/CT Practice (Paul Shreve, M.D.) ......................................................................................... 249 Infection and Inflammation Imaging (Don C. Yoo, M.D.) ................................................................................................ 263 Clinical Molecular Imaging: Beyond FDG and PET/CT (Arif Sheikh, M.D.) ..................................................................... 275 SAVE THE DATES - 2018 Winter Symposia 221 222 INTRODUCTION DIAGNOSTIC METHODS Modalities 18F NaF was one of the original • Planar bone scan agents. In fact, FDA • X-Ray • CT approved 18F NaF for clinical use in • MRI 1972. • SPECT/CT • PET • PET/CT Now, there are many choices to Bone Imaging Agents diagnose a bone metastasis. • 99mTc medronate (MDP) • 99mTc oxidronate (HDP) • 18F FDG • 18F NaF INTRODUCTION 18 INTRODUCTION HOW DOES F NaF WORK? ADVANTAGES OF 18F NaF PET/CT BONE SCANS • 18F produced by proton bombardment of 180, represents a precursor in pathway of 18F for
    [Show full text]
  • Application of Fluorine-18-Deoxyglucose Positron Emission Tomography and Gallium Scan for Assessment in a Patient with Adult-Onset Still’S Disease
    Arch Rheumatol 2016;31(2):180-183 doi: 10.5606/ArchRheumatol.2016.5754 CASE REPORT Application of Fluorine-18-Deoxyglucose Positron Emission Tomography and Gallium Scan for Assessment in a Patient With Adult-Onset Still’s Disease Jing-Uei HOU, Shih-Chuan TSAI, Wan-Yu LIN Department of Nuclear Medicine, Taichung Veterans General Hospital, Taichung, Taiwan ABSTRACT A 53-year-old female patient suffered from pain in almost her entire body, particularly the joints. Chest computed tomography revealed multiple lymphadenopathies over cervical, mediastinal, and axillary areas. A fluorine-18-deoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) revealed increased FDG uptake in many lymph nodes and the spleen. Lymphoma was suspected. However, the result of a biopsy showed no malignancy, and the gallium-67 citrate scan showed no gallium-avid tumor throughout the whole body. Adult-onset Still's disease was diagnosed and the patient responded well to steroid therapy. The follow-up PET/CT six months later showed complete remission of the FDG-avid lesions seen in the previous PET/CT. Our study suggests that FDG PET/CT combined with gallium-67 scan may be helpful in diagnosing patients with adult-onset Still’s disease. In addition, the use of FDG PET/CT alone may be useful for the evaluation of disease distribution, disease activity, and therapeutic response. Keywords: Adult-onset Still’s disease; fluorine-18-deoxyglucose; gallium-67; positron emission tomography/computed tomography. Adult-onset Still’s disease (AOSD) is an CASE REPORT inflammatory disorder of unknown cause. “Still’s disease” was first described in children by George A 53-year-old female patient suffered from pain Still in 1896.1 In 1971, the term “Adult-onset over most of her body, particularly the joints and Still’s disease” was used to describe patients the throat.
    [Show full text]
  • Gallium Imaging What to Expect During the Test • the Test Will Take 2 - 3 Days
    Nuclear Medicine Patient Information Gallium Imaging What to expect during the test • The test will take 2 - 3 days. Welcome to VCU Health Nuclear Medicine. We are Day 1 located in the Gateway Building, 2nd floor, 1200 East . A needle (IV) will be placed in a vein (intravenous Marshall Street. Our hours of operation are Monday catheter). through Friday, 7 am to 5 pm. Advanced scheduling is . A radioactive tracer will be administered through required for all nuclear medicine exams. Please review the IV. the following information about your test. Please call . You may go on with normal activities in between (804) 828-6828 to schedule your test or if you have any the injection and scan (eat and drink as normal). questions about your nuclear medicine exam. Day 2 (48 hours after injection) . You will lie down while the camera takes pictures What is it? of your whole body and possibly a SPECT (360 Imaging to detect certain types of infection, certain degree picture of your body) for 1 – 2 hours. inflammatory diseases or tumors. The images will be checked for quality by our Physician and more pictures may be needed. Why are you having this test? Day 3 (72 hours after injection) A gallium scan is done to: . You will lie down while the camera takes pictures • Detect the source of an infection that is causing a of your whole body and possibly a SPECT (360 fever (called a fever of unknown origin). degree picture of your body) for 1 – 2 hours. • Detect an abscess or certain infections, .
    [Show full text]
  • 4Th Quarter 2001 Medicare a Bulletin
    In This Issue... Medicare Guidelines on Telehealth Services Benefit Expansion, Coverage and Conditions for Reimbursement of These Services ............... 5 Medicare eNews Now Available Join Florida Medicare eNews Mailing List to Receive Important News and Information ........ 9 Expansion of Coverage on Percutaneous Transluminal Angioplasty Coverage Expansion and Claim Processing Instructions for Hospital Inpatient Services ..... 12 Skilled Nursing Facility Consolidated Billing Clarification to Health Insurance Prospective Payment System Coding and Billing Guidelines .............................................................................................................................. 15 Final Medical Review Policies 10060, 55873, 67221, 71250, 74150, 84155, 85007, 88141, 92225, 93303, A0430, G0030,G0104, G0108, J1561, J1745, J9212, and M0302 ...................................... 22 Outpatient Prospective Payment System Update and Changes to the Hospital Outpatient Prospective Payment System ...................... 87 Bulletin Reader Survey Provide your Comments and Feedback on the Medicare Part A Publication and/or our Provider Web Site ................................................................................................................ 103 Features From the Medical Director 3 he Medicare A Bulletin should be shared with all Administrative 4 T health care practitioners and General Information 5 managerial members of the General Coverage 11 provider/supplier staff. Publications issued after End Stage Renal Disease 13
    [Show full text]
  • Gallium Scan
    Gallium Scan What to expect at arrival: Please arrive 15-30 minutes prior to the appointment. The first place to go after arriving is admissions. The physician’s office should have provided a written order to the patient. Please take the order to admissions for registration. After checking in, the next stop will be the Radiology desk. The exam should start quickly from the scheduled time. Since Northeast Georgia is a major medical center there are emergencies that could arise that might extend wait time. Please try to be patient and be assured that we will begin your procedure as quickly as possible. What is Nuclear Medicine? Nuclear Medicine is a radiology modality that uses radiopharmaceuticals to image the body’s anatomy and physiology. The images are obtained after an intravenous injection or an oral administration of the radioactive pharmaceutical. Depending on the study, the images can take 20 to 30 minutes or could take a few hours or multiple days, depending on the study. The radiation from the pharmaceuticals is minimal, similar to an x-ray. Patient Prep: There are no restrictions prior to a Gallium Scan. The day before the exam the patient needs to take a light laxative like Dulcolax. The patient can eat, drink, and take medications prior to the injection and afterward. Please let the technologist know if there is any possibility that you may be pregnant. Your Gallium Scan: When you are brought to the Nuclear Medicine department, a technologist will verify the orders and patient identification. A technologist will ask a series of questions and explain the procedure.
    [Show full text]
  • RADIOLOGY HELP DOCUMENTS Procedures and Preps
    RADIOLOGY HELP DOCUMENTS Procedures and Preps YOUR HEALTH : OUR MISSION This document is designed to be a tool to assist you with Pre-Medication Guidelines for Contrast Allergies, Creatinine Requirements, Interventional Procedures and Biopsies, Clinical Indication Guidelines and Patient Preps. Scheduling Same day, outpatient exam: Contact Radiology at 605-882-7770 A future outpatient exam: Contact Central Scheduling at 605-882-7690 or 882-5438 or 882-5448 If a patient needs pre-medication for a previous contrast reaction you need to date and sign and obtain the pre-medication for the patient—the “Contrast Reaction Prophylaxis Suggestions for Premedication” *Fax requests for Oral Medications to the Campus Pharmacy at 605-882-7704, M-F 0830-1700, other hours to Main Pharmacy at 605-882-7694 *Fax Requests for Injectable Medications to Central Scheduling 605-882-6704 • Reports will still continue to come to the appropriate printers in all patient care areas • Reports can be accessed in CPSI, Chartlink, PACS and www.plhspacs.com • ER reports will be routed to the ED printer 1. Stat reports are 30 minutes or less 2. Inpatients and ASAP 4 hours or less 3. Routine outpatient reports are 24 hours from the time the exam is scheduled • Keep in mind, if an exam from any outside or attached clinic (Cardiology, Urology, Nephrology, Cancer Center, GLO, Dr. Jones, Brown Clinic, Sanford Clinic, Hanson/Moran Eye Clinic, Innovative Pain Clinic and VA Clinic) is ordered, the results will be available 24 hours from the time the exam is scheduled. If the patients follow up appointment to see the clinician and review the results is less than 24 hours from the time the exam is conducted, be sure to indicate this on the order so we can submit as an ASAP order.
    [Show full text]
  • Scintigraphic Localization of Lymphatic Leakage Site After Oral Administration Ofiodine-123-IPPA
    ACKNOWLEDGMENTS 13. Lin WY, Lan JL, Cheng KY, Wang SJ. Value of gallium-67 scintigraphy in monitoring the renal activity in lupus nephritis. Scan J Rheum 1998:27:42-45. This study was supported in part by a grant from the Institute of 14. Cruzado JM. Poveda R. Mana J. et al. Interstitial nephritis in sarcoidosis: simultaneous Nuclear Energy Research and National Science Council, Republic multiorgan involvement. Am J Kidney Dis 1995:26:947-951. of China (NSC 87-2314-B-075A-003). 15. Pagniez DC. MacNamara E, Beuscart R, Wambergue F, Dequiet P. Tacque! A. Gallium scan in the follow-up of sarcoid granulomatosus nephritis. Am J Nephrol 1987:7:326-327. REFERENCES 16. Wood BC. Sharma JN, Germann DR, Wood WG, Crouch TT. Gallium-67 citrate 1. Steinberg AD, Steinberg SC. Long-term preservation of renal function in patients with imaging in noninfectious interstitial nephritis. Arch Inlern Med 1978:138:1665-1666. lupus nephritis receiving treatment that includes cyclophosphamide versus those 17. Bakir AA, Lopez-Majano V, Hryhorczuk DO. Rhee HL, Dunca G. Appraisal of lupus treated with prednisone only. Arthritis Rheum 1991:34:945-950. nephritis by renal imaging with gallium-67. Am J Med 1985:79:175-182. 2. Felson DT. Anderson J. Evidence for the superiority of immunosuppressive drugs and 18. Tsan M. Mechanism of gallium-67 accumulation in inflammatory lesions. J NucíMed prednisone over prednisone alone in lupus nephritis. N Engl J Med 1984;311:1528- 1985:26:88-93. 1533. 19. Tsan M, Scheffel U. Gallium-67 accumulation in inflammatory lesions. J NucíMed 3.
    [Show full text]